RAPM Focus
Episode 54: Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis
18:17
Knee osteoarthritis is a leading cause of chronic pain and disability, with limited disease modifying therapies—yet glucagon-like peptide 1 receptor agonists may reduce progression to total knee arthroplasty. In this episode of RAPM Focus, Executive Editor Anahi Perlas, MD, FRCPC, explores whether or not GLP-1 receptor agonists may reduce the risk of arthroplasty for total knee osteoarthritis…